- Home
- SKLZ vs TLSA Comparison
SKLZ vs TLSA Comparison
Compare SKLZ & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKLZ
- TLSA
- Stock Information
- Founded
- SKLZ 2012
- TLSA 2013
- Country
- SKLZ United States
- TLSA United Kingdom
- Employees
- SKLZ N/A
- TLSA N/A
- Industry
- SKLZ EDP Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- SKLZ Technology
- TLSA Health Care
- Exchange
- SKLZ Nasdaq
- TLSA Nasdaq
- Market Cap
- SKLZ 99.0M
- TLSA 85.9M
- IPO Year
- SKLZ N/A
- TLSA 2000
- Fundamental
- Price
- SKLZ $5.49
- TLSA $0.90
- Analyst Decision
- SKLZ Buy
- TLSA
- Analyst Count
- SKLZ 4
- TLSA 0
- Target Price
- SKLZ $10.67
- TLSA N/A
- AVG Volume (30 Days)
- SKLZ 66.9K
- TLSA 151.0K
- Earning Date
- SKLZ 11-06-2024
- TLSA 05-10-2024
- Dividend Yield
- SKLZ N/A
- TLSA N/A
- EPS Growth
- SKLZ N/A
- TLSA N/A
- EPS
- SKLZ N/A
- TLSA N/A
- Revenue
- SKLZ $118,060,000.00
- TLSA N/A
- Revenue This Year
- SKLZ N/A
- TLSA N/A
- Revenue Next Year
- SKLZ $7.32
- TLSA N/A
- P/E Ratio
- SKLZ N/A
- TLSA N/A
- Revenue Growth
- SKLZ N/A
- TLSA N/A
- 52 Week Low
- SKLZ $4.51
- TLSA $0.41
- 52 Week High
- SKLZ $7.48
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- SKLZ 45.23
- TLSA 43.74
- Support Level
- SKLZ $5.20
- TLSA $0.90
- Resistance Level
- SKLZ $5.66
- TLSA $0.97
- Average True Range (ATR)
- SKLZ 0.21
- TLSA 0.08
- MACD
- SKLZ 0.01
- TLSA -0.00
- Stochastic Oscillator
- SKLZ 40.85
- TLSA 24.99
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.